Members with a chronic condition and an untreated behavioral health comorbidity do not cost twice as much as members with the chronic condition alone. They cost materially more. That gap is not explained by the behavioral health diagnosis. It is explained by what untreated behavioral health does to the clinical outcomes, the medication adherence, and the utilization patterns of every other condition the member is managing.

Behavioral health is not a separate cost category in your claims portfolio. It is a multiplier applied to every other category. The member with diabetes and untreated depression does not just generate behavioral health spend. They generate worse diabetes outcomes, higher acute care utilization, lower medication adherence, and faster progression to the complications that produce catastrophic claims.

Most employer benefits architectures are not designed to see this. Behavioral health is routed to an EAP or a standalone mental health benefit, tracked in its own reporting silo, and evaluated on access metrics and session counts rather than its impact on the conditions it is silently amplifying across the rest of the portfolio.

That is the structural failure. And it is costing more than the behavioral health line item reflects.

Why the EAP model cannot capture the cost multiplier

Employee assistance programs were designed to address short-term personal crises: workplace stress, bereavement, relationship problems, brief episodes of anxiety. They were not designed to address the persistent, clinically significant behavioral health burden that co-occurs with chronic physical conditions at scale.

The EAP model has three structural limitations that prevent it from functioning as a clinical cost management tool. First, utilization is self-directed: members with the most significant behavioral health burden, those managing depression alongside chronic disease, are the least likely to self-navigate to a resource they do not know exists or feel stigmatized about accessing. Second, session limits cap the intervention at exactly the moment sustained engagement begins to produce clinical benefit. Third, EAP outcomes are measured in isolation, with no visibility into the member's chronic condition claims, no shared data with their diabetes or MSK program, and no accountability for what happens to their A1C or their pain score after they complete their sessions.

An EAP is not an integrated behavioral health strategy. It is access infrastructure for a narrow use case, deployed as if it were the full solution to a much larger problem.

The behavioral health multiplier across your highest-cost conditions

Solera Health blog inset labeled "High-cost condition 01: Diabetes," with a droplet diabetes icon. It explains adults with T2D are two to three times more likely to experience depression, which doesn't just add a behavioral health cost but degrades every lever the program depends on — monitoring, adherence, diet, and activity — so a member carrying untreated depression is receiving an intervention designed for a clinically different population, and the outcomes data reflects that gap. A navy "The multiplier in practice" band reads: the members most likely to disengage are disproportionately those carrying untreated behavioral health burden, and that denominator problem is invisible in single-condition reporting.

Solera Health blog inset labeled "High-cost condition 02: Hypertension," with a droplet hypertension icon. It explains the link between stress, anxiety, and blood pressure is physiologically direct, with chronic sympathetic activation sustaining elevated vascular resistance and heart rate, so for members in the Elevated or Stage 1 category unaddressed anxiety is a clinical barrier to the blood pressure normalization lifestyle programs are designed to achieve, producing lower control rates and more medication escalation. A navy "The multiplier in practice" band reads: every member who fails to normalize because unaddressed anxiety maintains their sympathetic activation enters the medication cost chain unnecessarily, and behavioral health is a clinical prerequisite, not a soft add-on.

Solera Health blog inset labeled "High-cost condition 03: MSK & chronic pain," with a droplet spine icon. It explains the bidirectional link between chronic pain and behavioral health is among the best-documented comorbidity patterns: depression lowers pain tolerance and rehabilitation engagement, while chronic pain drives depression through inflammation, disrupted sleep, and isolation, resulting in longer recovery, higher surgical rates, and one of the strongest predictors of opioid escalation. A navy "The multiplier in practice" band reads: a program that improves pain scores for the 60% who complete it without addressing the behavioral health barriers driving dropout in the other 40% delivers program-level outcomes for a self-selected subset, not population cost avoidance.

Solera Health blog inset labeled "High-cost condition 04: Oncology & complex care," with a droplet stethoscope icon. It explains depression and anxiety affect a substantial majority of cancer patients during active treatment and, untreated, are associated with lower treatment adherence, higher symptom burden, increased ED utilization, and worse survival outcomes in several cancer types. A navy "The multiplier in practice" band reads: a cancer member with untreated depression is more likely to present to the ED, discontinue daily-commitment protocols, and require complication-driven hospitalizations, so behavioral health integration here is a utilization management intervention, not a quality-of-life benefit.

What integrated behavioral health looks like in practice

Addressing behavioral health as a clinical cost multiplier rather than a standalone benefit category requires three structural changes that most benefits designs have not yet made.

  • Shared data across condition programs. If a member's diabetes program vendor cannot see their behavioral health utilization, and their behavioral health program cannot see their A1C trend, there is no integration. There is parallel management of conditions that are clinically inseparable.
  • Behavioral health screening embedded in every condition program. Screening at intake for depression and anxiety should not be optional or member-initiated. It should be a standard component of every chronic condition enrollment, with a defined clinical protocol for what happens when a member screens positive.
  • Outcome measurement that crosses condition boundaries. If your behavioral health vendor reports session completion and your diabetes vendor reports A1C improvement but neither report connects to the other, you are measuring program performance in two silos. The measurement that matters is what happens to A1C, blood pressure, pain scores, and surgical rates when behavioral health is integrated at the population level.

Solera Health's network addresses Behavioral Health as a connected condition area across Weight Management, Diabetes, MSK, and Hypertension programs,  identifying members carrying elevated health risk and routing them to programs designed for clinical complexity. Outcomes are tracked through medical claims across condition boundaries, not within them.

Behavioral health is not a line item in your benefits portfolio. It is the variable that determines whether every other line item performs.

Solera Health connects benefits leaders and health plan executives to evidence-based digital health programs spanning Behavioral Health, Diabetes, MSK, Hypertension, and Weight Management, matched to member clinical profiles and measured through integrated medical claims outcomes.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.